Why the study?
Does the CYP3A4*22 allele increase bleeding risk in ticagrelor users?
Does the CYP3A4*22 allele increase bleeding risk in ticagrelor users?
Answers are grounded in this paper and cite their sources.
The CYP3A4*22 allele may be associated with an increased risk of bleeding in patients taking ticagrelor.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Liedes et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: